Kumar R - Search Results

1

DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.

Kaur G, Cholia RP, Mantha AK, Kumar R. Kaur G, et al. Among authors: kumar r. J Med Chem. 2014 Dec 26;57(24):10241-56. doi: 10.1021/jm500865u. Epub 2014 Oct 15. J Med Chem. 2014. PMID: 25280182

2

A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.

Nepali K, Singh G, Turan A, Agarwal A, Sapra S, Kumar R, Banerjee UC, Verma PK, Satti NK, Gupta MK, Suri OP, Dhar KL. Nepali K, et al. Among authors: kumar r. Bioorg Med Chem. 2011 Mar 15;19(6):1950-8. doi: 10.1016/j.bmc.2011.01.058. Epub 2011 Feb 23. Bioorg Med Chem. 2011. PMID: 21353569

3

N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors.

Nepali K, Agarwal A, Sapra S, Mittal V, Kumar R, Banerjee UC, Gupta MK, Satti NK, Suri OP, Dhar KL. Nepali K, et al. Among authors: kumar r. Bioorg Med Chem. 2011 Sep 15;19(18):5569-76. doi: 10.1016/j.bmc.2011.07.039. Epub 2011 Jul 26. Bioorg Med Chem. 2011. PMID: 21862335

4

Recent advancements in small molecule inhibitors of insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase as anticancer agents.

Negi A, Ramarao P, Kumar R. Negi A, et al. Among authors: kumar r. Mini Rev Med Chem. 2013 Apr 1;13(5):653-81. doi: 10.2174/1389557511313050004. Mini Rev Med Chem. 2013. PMID: 23373648 Review.

5

4,5-Dihydro-1H-pyrazole: an indispensable scaffold.

Alex JM, Kumar R. Alex JM, et al. Among authors: kumar r. J Enzyme Inhib Med Chem. 2014 Jun;29(3):427-42. doi: 10.3109/14756366.2013.795956. Epub 2013 Jul 1. J Enzyme Inhib Med Chem. 2014. PMID: 23808806 Review.

6

Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity.

Baviskar AT, Banerjee UC, Gupta M, Singh R, Kumar S, Gupta MK, Kumar S, Raut SK, Khullar M, Singh S, Kumar R. Baviskar AT, et al. Among authors: kumar s, kumar r. Bioorg Med Chem. 2013 Sep 15;21(18):5782-93. doi: 10.1016/j.bmc.2013.07.016. Epub 2013 Jul 17. Bioorg Med Chem. 2013. PMID: 23920485

7

Medicinal attributes of pyrazolo[3,4-d]pyrimidines: a review.

Chauhan M, Kumar R. Chauhan M, et al. Among authors: kumar r. Bioorg Med Chem. 2013 Sep 15;21(18):5657-68. doi: 10.1016/j.bmc.2013.07.027. Epub 2013 Jul 20. Bioorg Med Chem. 2013. PMID: 23932070 Review.

8

Synthesis and xanthine oxidase inhibitory activity of 5,6-dihydropyrazolo/pyrazolo[1,5-c]quinazoline derivatives.

Kumar D, Kaur G, Negi A, Kumar S, Singh S, Kumar R. Kumar D, et al. Among authors: kumar s, kumar r. Bioorg Chem. 2014 Dec;57:57-64. doi: 10.1016/j.bioorg.2014.08.007. Epub 2014 Aug 30. Bioorg Chem. 2014. PMID: 25222504

9

Pyrazoloquinazolines: Synthetic strategies and bioactivities.

Garg M, Chauhan M, Singh PK, Alex JM, Kumar R. Garg M, et al. Among authors: kumar r. Eur J Med Chem. 2015 Jun 5;97:444-61. doi: 10.1016/j.ejmech.2014.11.051. Epub 2014 Nov 26. Eur J Med Chem. 2015. PMID: 25438709 Review.

10

Design, microwave-mediated synthesis and biological evaluation of novel 4-aryl(alkyl)amino-3-nitroquinoline and 2,4-diaryl(dialkyl)amino-3-nitroquinolines as anticancer agents.

Chauhan M, Rana A, Alex JM, Negi A, Singh S, Kumar R. Chauhan M, et al. Among authors: kumar r. Bioorg Chem. 2015 Feb;58:1-10. doi: 10.1016/j.bioorg.2014.11.004. Epub 2014 Nov 13. Bioorg Chem. 2015. PMID: 25462621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18,382 results

Search Page